Twi Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TWI PHARMS INC, and what generic and branded alternatives to TWI PHARMS INC drugs are available?
TWI PHARMS INC has one approved drug.
There is one tentative approval on TWI PHARMS INC drugs.
Summary for Twi Pharms Inc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Twi Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Twi Pharms Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 091281-001 | Jan 31, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Twi Pharms Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 091281-002 | Jan 31, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
